Aimbe Public Policy Institute


This institute is open to current undergraduate and graduate students, post docs, and early career fellows (including executive branch fellows) in Medicine, Engineering, and Health Sciences interested in the public policy landscape shaping science, innovation, and discovery.

Program Description

This program explores how public policies shape medical and biological engineering. You will have the opportunity to hear from regulatory agencies such as the Food and Drug Administration (FDA) and the National Institute of Health (NIH). You will listen to policy experts and thought leaders explain the ramifications of proposed regulatory and policy initiatives. You will attend sessions taught by industry giants in the medical device and innovation sector. You will meet with government decision makers developing the public policies that govern patents, medical devices, pharma, and health and science legislation. You will network with early career participants in health and engineering across the nation.

By the end of the Institute, participants will be able to:

  • Describe the current regulatory science framework and its role in the decision-making about the risks and benefits of medical products.
  • Describe federal health policy initiatives that shape research and funding decisions
  • Understand the role of the executive and legislative branches in developing policies governing the scientific enterprise
  • Identify hot button issues in regulatory policy and health policy
  • Identify the numerous stakeholders shaping public health in Washington, affecting the nation

Notable Program Speakers:

  • Robbie Barbero, Ph.D., Assistant Director for Biological Innovation, White House Office of Science and Technology Policy
  • Justin Sanchez, Ph.D., Director, Biological Technologies Office, The Defense Advanced Research Projects Agency (DARPA)
  • Patricia Shrader, J.D., Vice President, Global Regulatory Affairs, Medtronic
  • Kyle J. Myers, Ph.D., Director, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, FDA
  • Rick Naples, Executive Vice President and Chief Regulatory Officer, BD
  • Robert D. Atkinson, Ph.D. President, Information Technology and Innovation Foundation
  • Meena Seshamani, M.D., Ph.D., Director, Office of Health Reform, Department of Health and Human Services
  • Susan Wood, Ph.D., Associate Professor of Health Policy, George Washington University School of Public Health and Health Services; Director, Jacobs Institute of Women’s Health Services
  • Matt Hourihan, Director, R&D Budget and Policy Program, American Association for the Advancement of Science (AAAS)


The cost for the Institute is $395. No travel awards or scholarships are currently offered. Registration is now closed.

Meeting Location

Alston & Bird LLP

950 F Street NW, 2nd floor conference room    

Washington, DC 20004

Hotel Information

AIMBE does not reserve a block of rooms for the Policy Institute. Listed below are several hotels near the meeting location, where the Institute will take place. The meeting location is across from the Gallery Place/Chinatown Metro stop on the Red, Green, and Yellow lines. For more information about traveling to and from the meeting location, please see their website.

Courtyard Washington Convention Center (closest hotel)
900 F St NW, Washington, DC 20004

Phone: (202) 638-4600

Renaissance Washington, DC  (.04 mile, 8 minute walk)
999 9th St NW, Washington, DC 20001

Phone: (202) 898-9000

Marriott Fairfield Inn & Suites (.05 mile, 11 minute walk)
500 H St NW, Washington, DC 20001

Phone: (202) 289-5959 


Contact Sarah Mandell, AIMBE Director of Research and Programming


White House Official Robbie Barbero, Ph.D., Assistant Director for Biological Innovation for the Office of Science and Technology Policy address the White House Role in Science Policymaking.

Participants network with Philip Desjardins, J.D., Vice President of Global Regulatory Affairs & Intelligence for Medical Devices at Johnson & Johnson.

The AIMBE FDA Scholars discuss regulatory policy with Patricia Shrader, J.D., Vice President of Global Regulatory Affairs for Medtronic.

Public Policy Institute 2016 Flyer